Skip to main content
logo
Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
8.94
+0.22 (2.52%)
Oct 30, 2026, 9:37 AM EDT - Market open

Moleculin Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
9105293053
Market Cap Growth
-40.37%99.75%-82.21%-5.48%-42.91%5.54%
Enterprise Value
24-45-20-22
Last Close Price
8.7266.20850.006438.007950.0013949.99

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
0.270.680.461.100.580.67
P/TBV Ratio
19.342.6485.041.920.740.78

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.020.040.020.010.00
Net Debt / Equity Ratio
-0.60-0.57-0.34-0.88-0.82-0.90
Net Debt / EBITDA Ratio
0.240.340.140.781.403.10
Net Debt / FCF Ratio
0.280.380.160.971.543.73
Quick Ratio
0.781.300.803.478.9619.59
Current Ratio
0.941.410.973.869.4620.02
Return on Equity (ROE)
-1371.64%-256.05%-139.74%-76.07%-44.25%-32.86%
Return on Assets (ROA)
-84.57%-80.35%-60.39%-38.73%-27.07%-25.38%
Return on Capital Employed (ROCE)
-245.20%-164.40%-230.30%-94.40%-58.20%-28.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2147.04%-329.27%-510.49%-103.79%-95.65%-29.90%
FCF Yield
-298.59%-223.06%-467.90%-82.69%-91.30%-35.69%
SEC Filings: 10-K · 10-Q